| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |